2015-11-07 15:31:02
In this study, the authors evaluated the effect of omega-3 supplementation on IL-6 and CRP level in chronic ambulatory peritoneal dialysis (CAPD) patients [1]. IL-6 and CRP can predict inflammatory state in end stage renal disease patients. This clinical trial was performed in 40 patients in Iran. One group received 1000mg of omega-3 three times a day for 8 weeks. The other group received placebo. The results showed that there were not any differences in CRP and IL-6 level in the beginning and end of the study between the groups. The authors conclude that omega-3 did not affect inflammatory markers.
References
- Naini AE, et al. Effect of omega-3 supplementation on inflammatory parameters in patients on chronic ambulatory peritoneal dialysis. Adv Biomed Res. 2015;4:167.